Technical comment on: Rachamin et al. Statin treatment and LDL target value achievement in Swiss general practice - a retrospective observational study

Swiss Med Wkly. 2020 Nov 23:150:w20373. doi: 10.4414/smw.2020.20373. eCollection 2020 Nov 16.

Authors

Michel Romanens¹, Edward A Schober², Ansgar Adams³, Sandor Balint⁴, Walter Warmuth⁵

Affiliations

¹ Vascular Risk Foundation, Olten, Switzerland.
² Fairfond Stiftung für Fairness im Gesundheitswesen, Olten, Switzerland.
³ BAD Gesundheitsvorsorge und Sicherheitstechnik GmbH, Bonn, Germany.
⁴ Privatpraxis, Binningen, Switzerland.
⁵ Gesundheitsforen Leipzig, Germany.

PMID: 33232511
DOI: 10.4414/smw.2020.20373

No abstract available

Publication types

Comment

MeSH terms

Cholesterol, LDL
General Practice*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Retrospective Studies
Switzerland

Substances

Cholesterol, LDL
Hydroxymethylglutaryl-CoA Reductase Inhibitors